Table 4.
Characteristics of the included studies
| Study | Year | Study design | Country | Sample description | Intervention | Follow-up |
|---|---|---|---|---|---|---|
| 1. Diracoglu et al. | 2009 | Prospective | Turkey | Arthrocentesis-54 individuals, 33.4 (15–63) years Male-3 Female-51 | Arthrocentesis Group-Lavage of superior joint space with 60 ml Ringer lactate solution | Baseline, 1st month, 3rd month, 6th month |
| Conventional-56 individuals, 34.8 (17–61)years, Male-7 Female-49 | Conventional group-Stabilization splint, 20 min hot pack daily and home exercise programme | |||||
| 2. Hosgor et al. | 2017 | Randomized clinical trial | Turkey | N = 40, Age—Not mentioned, Gender—Not mentioned | Divided into four groups | Baseline, 1st month, 3rd month, 6th month |
| Group 1—Occlusal splint therapy | ||||||
| Group 2—Arthrocentesis with 100 ml lactated Ringer’s solution | ||||||
| Group 3—NSAID (tenoxicam) 20 mg tablets | ||||||
| Group 4—Low-level laser therapy (Nd:YAG, 1064 nm) | ||||||
| 3. Malekzadeh et al. | 2019 | Randomized clinical trial | Sweden | Group 1–12 individuals, 32.5 ± 17.5 years, Female-10, Male-2 | Group 1—Non-invasive group, this group undergone self-exercise and palliative treatment, Occlusal splints given when bruxism activity diagnosed | Baseline, 3rd month, 6th month, 12th month |
| Group 2–12 individuals, 26.7 ± 7.9 years, Female-9, Male-3 | Group 2—Minimally invasive group, this group undergone arthrocentesis with 40-60 ml of sodium chloride solution | |||||
| 4. Ohnuki et al. | 2005 | Retrospective study | Japan | N = 85, 41.8 ± 17.7 years, Female-76, Male-9 | All the patients diagnosed with temporomandibular joint disorders, who were previously treated divided into four groups | Baseline, 1 year after treatment |
| Group 1—Splint therapy | ||||||
| Group 2—Pumping manipulation | ||||||
| Group 3—Arthrocentesis | ||||||
| Group 4—Arthroscopic surgery | ||||||
| 5. Tatli et al. | 2017 | Randomized clinical trial | Turkey | Group 1–40 individuals, 35.2 ± 9.4 years, Female-35, Male-5 | Group 1—Arthrocentesis with isotonic sodium chloride solution followed by sodium hyaluronate injection | Baseline, 1st month, 3rd month, 6th month |
| Group 2—40 individuals, 38.9 ± 11.3 years, Female-39, Male-1 | Group 2—Stabilization splint followed by Arthrocentesis and sodium hyaluronate injection | |||||
| Group 3—40 individuals, 34.8 ± 8.7 years, Female-33, Male-7 | Group 3—Stabilization splint only |